Evidence map›Paper›PMID 40285667›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025

A Reversible and Dynamic Surface Functionalization for Fluidity Controlled Multivalent Recognition of Lectins and Bacteria.

Thomas Hix-Janssens, Adam Tillo, Hanna Isaieva, Zita Lopes da Silva, Zahra Fatahi, Michele Larocca, Gustav Sedelius, Sara Björk Sigurdardóttir, Yulia Sergeeva, Tiba Al-Dujaili and 3 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Thomas Hix-JanssensBiofilms Research Center for Biointerfaces, Department of Biomedical Science, Faculty of Health and Society, Malmö University, Malmö, 205 06, Sweden.
Adam TilloBiofilms Research Center for Biointerfaces, Department of Biomedical Science, Faculty of Health and Society, Malmö University, Malmö, 205 06, Sweden.
Hanna IsaievaBiofilms Research Center for Biointerfaces, Department of Biomedical Science, Faculty of Health and Society, Malmö University, Malmö, 205 06, Sweden.
Zita Lopes da SilvaBiofilms Research Center for Biointerfaces, Department of Biomedical Science, Faculty of Health and Society, Malmö University, Malmö, 205 06, Sweden.
Zahra FatahiBiofilms Research Center for Biointerfaces, Department of Biomedical Science, Faculty of Health and Society, Malmö University, Malmö, 205 06, Sweden.
Michele LaroccaBiofilms Research Center for Biointerfaces, Department of Biomedical Science, Faculty of Health and Society, Malmö University, Malmö, 205 06, Sweden.
Gustav SedeliusBiofilms Research Center for Biointerfaces, Department of Biomedical Science, Faculty of Health and Society, Malmö University, Malmö, 205 06, Sweden.
Sara Björk SigurdardóttirBiofilms Research Center for Biointerfaces, Department of Biomedical Science, Faculty of Health and Society, Malmö University, Malmö, 205 06, Sweden.
Yulia SergeevaBiofilms Research Center for Biointerfaces, Department of Biomedical Science, Faculty of Health and Society, Malmö University, Malmö, 205 06, Sweden.
Tiba Al-DujailiBiofilms Research Center for Biointerfaces, Department of Biomedical Science, Faculty of Health and Society, Malmö University, Malmö, 205 06, Sweden.
Julia R DaviesSection for Oral Biology and Pathology, Faculty of Odontology, Malmö University, Malmö, 205 06, Sweden.
Kushagr PunyaniSpermosens AB, The Spark, Medicon Village, Lund, Sweden.
Börje SellergrenBiofilms Research Center for Biointerfaces, Department of Biomedical Science, Faculty of Health and Society, Malmö University, Malmö, 205 06, Sweden.ORCID https://orcid.org/0000-0002-2392-3305

Funding

H2020 Marie Skłodowska-Curie Actions 794999H2020 Marie Skłodowska-Curie Actions H2020-MSCA-IF-2017Malmö University Foresight programmeStiftelsen för Kunskaps- och Kompetensutveckling 20190126Stiftelsen för Kunskaps- och Kompetensutveckling 20210044Stiftelsen för Kunskaps- och Kompetensutveckling 20220127Vetenskapsrådet VR-MH-2021-02118Vetenskapsrådet VR-NT 2018-04930Vetenskapsrådet VR-NT2023-05344Vinnova 2022-01370
6 · The paper itself

Abstract

The paper reports the design of multivalent bacterial receptors based on reversible self-assembled monolayers (rSAMs) on gold and glass substrates, mimicking the ligand display on host cells and extracellular matrices. The layers consist of α-(4-amidinophenoxy)alkanes decorated at the ω-position with β-galactose (Gal) or sialic acid (SA). The former acts as a mobile ligand binding to the complementary adhesin, LecA, a key virulence factor of the multi-drug-resistant bacterium Pseudomonas aeruginosa (PA). Binary amphiphile mixtures containing either of these ligands, spontaneously self-assemble on carboxylic acid terminated SAMs on gold or glass surfaces to form rSAMs that are easily tunable with respect to the ligand ratio. It is shown that this results in the ability to construct multi-reusable surfaces featuring strong affinity for the bacterial adhesin and recognitive surfaces for bacteria, the latter demonstrated by incubating a culture of PA or the oral commensal species Streptococcus gordonii (SG) on either Gal or SA functionalized rSAMs. In contrast to the mobile ligand display, surfaces featuring covalently attached "static" ligands exhibited low LecA affinity. This approach to wet chemical surface functionalization is unique in imparting both rapid restorability and adaptability, the latter compatible with heteromultivalent receptor designs for boosting lectin and bacteria affinity and specificity.

Indexed as

Adhesins, BacterialLectinsPseudomonas aeruginosaGoldLigandsSurface PropertiesAdhesins, BacterialGoldLectinsLigandsbacterial recognitionmembrane mimicmultivalent receptorrewritable surfacesrSAM

Identifiers

PMID40285667
PMCPMC12165121

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.